CR Trademark

Trademark Overview


On Monday, November 15, 2021, a trademark application was filed for CR with the United States Patent and Trademark Office. The USPTO has given the CR trademark a serial number of 97124708. The federal status of this trademark filing is REGISTERED as of Tuesday, March 7, 2023. This trademark is owned by Corregene Biotechnology Co., Ltd. The CR trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Chemical reagents for medical or veterinary purposes; Cultures of microorganisms for medical or veterinary use; Diagnostic preparations for medical purposes; Enzyme preparations for medical purposes; Stem cells for medical purposes; Stem cells for veterinary purposes; Surgical implants comprised of living tissues
cr

General Information


Serial Number97124708
Word MarkCR
Filing DateMonday, November 15, 2021
Status700 - REGISTERED
Status DateTuesday, March 7, 2023
Registration Number6994906
Registration DateTuesday, March 7, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements


Description of MarkThe mark consists of an abstract design consisting of circular and curved line shapes depicting the letters "CR".
Goods and ServicesBiological preparations for the treatment of cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Chemical reagents for medical or veterinary purposes; Cultures of microorganisms for medical or veterinary use; Diagnostic preparations for medical purposes; Enzyme preparations for medical purposes; Stem cells for medical purposes; Stem cells for veterinary purposes; Surgical implants comprised of living tissues
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCorregene Biotechnology Co., Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBeijing 102200
CN

Party NameCorregene Biotechnology Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBeijing 102200
CN

Party NameCorregene Biotechnology Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBeijing 102200
CN

Trademark Events


Event DateEvent Description
Tuesday, March 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 7, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 30, 2022NON-FINAL ACTION E-MAILED
Tuesday, August 30, 2022NON-FINAL ACTION WRITTEN
Thursday, August 25, 2022ASSIGNED TO EXAMINER
Saturday, November 20, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, November 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 18, 2021NEW APPLICATION ENTERED